RASSF2 and ovarian endometriosis: The results of this study indicate that the hypermethylation of the RASSF2 promoter, leading to epigenetic inactivation, may play a crucial role in the early stages of ovarian endometriosis progressing towards malignancy (60) (refer to Table 2).